CRL — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates CRL as Bearish with 81% confidence in the Healthcare sector.
AI Analysis Summary
the signal indicates caution regarding this stock is bearish due to severe financial leverage, declining profitability, and weak macroeconomic alignment.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade F — 15/100
- Bill Ackman (Activist Investing): Grade C — 57/100
- Ray Dalio (Macro/Risk Parity): Grade D — 35/100
Consensus: Bearish
Price Intelligence
- Current price: $171.23
- Price target: $149.33 (-12.8%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
CRL is in the “Strong Cash Flow” cluster alongside WSM, WY, WTW, WMT, WELL (127 stocks total). 2 of 127 peers are currently bullish.